Riverine Ventures logo

Riverine Ventures

North America, California, United States, Sausalito

Description

Riverine Ventures partners with emerging new company leaders to bring solutions to complex challenges in healthcare and the life sciences.

Investor Profile

Riverine Ventures has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Developer Tools
  • Enterprise Software
  • Genetics
  • Medical
  • Software
  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Riverine Ventures frequently co-invest with?

BroadOak Capital Partners
North America, Maryland, United States, Bethesda
Co-Investments: 1
Red Cedar Ventures
North America, Michigan, United States, East Lansing
Co-Investments: 1
IrishAngels
North America, Illinois, United States, Chicago
Co-Investments: 1
Spring Mountain Capital
North America, New York, United States, New York
Co-Investments: 1
Michigan Rise
North America, Michigan, United States, East Lansing
Co-Investments: 1
Michigan Angel Fund
North America, Michigan, United States, Ann Arbor
Co-Investments: 1
Beringea
North America, Michigan, United States, Farmington Hills
Co-Investments: 1
Invest Detroit Ventures
North America, Michigan, United States, Detroit
Co-Investments: 1
A
North America, Michigan, United States, Farmington Hills
Co-Investments: 1
Green Park & Golf Ventures
North America, Texas, United States, Dallas
Co-Investments: 1

What are some of recent deals done by Riverine Ventures?

CellFE

Alameda, California, United States

CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.

BiotechnologyHealth Care
Series ASep 27, 2023
Amount Raised: $22,000,000
Genomenon

Ann Arbor, Michigan, United States

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.

Developer ToolsEnterprise SoftwareGeneticsMedicalSoftware
Series BMar 8, 2022
Amount Raised: $20,000,000